[1]
WANG, N. et al. 2013. Comparison of the forty-eight week efficacy between telbivudine and entecavir in HBeAgpositive Asian patients with chronic hepatitis B: A meta-analysis. Turkish Journal of Gastroenterology. 24, 3 (Jan. 2013), 230–240. DOI:https://doi.org/10.4318/tjg.2013.0680.